118431-03-1

Basic information

• Product Name: Butanoic acid, 2-[(3-nitrophenyl)methylene]-3-oxo-, methyl ester, (E)-
• CAS NO: 118431-03-1
• Molecular Formula: C12H11NO5
• Molecular Weight: 249.223
• Mol File: 118431-03-1.mol

Chemical Properties

• CAS DataBase Reference: Butanoic acid, 2-[(3-nitrophenyl)methylene]-3-oxo-, methyl ester, (E)-(CAS DataBase Reference)
• NIST Chemistry Reference: Butanoic acid, 2-[(3-nitrophenyl)methylene]-3-oxo-, methyl ester, (E)-(118431-03-1)
• EPA Substance Registry System: Butanoic acid, 2-[(3-nitrophenyl)methylene]-3-oxo-, methyl ester, (E)-(118431-03-1)

Safety Data

• Hazardous Substances Data: 118431-03-1(Hazardous Substances Data)

Upstream product

• 110-89-4 piperidine 
• 99-61-6 3-nitro-benzaldehyde 
• 105-45-3 acetoacetic acid methyl ester 

Downstream Products

• 120004-43-5 (5-Methyl-thiophen-2-yl)-[1-(3-nitro-phenyl)-meth-(E)-ylidene]-amine 
• 106970-88-1 2,6-Dimethyl-4-(3-nitro-phenyl)-4,7-dihydro-thieno[2,3-b]pyridine-5-carboxylic acid methyl ester 
• 120004-41-3 [1-(3-Nitro-phenyl)-meth-(E)-ylidene]-(4-phenyl-thiophen-2-yl)-amine 
• 106970-69-8 methyl 4,7-dihydro-6-methyl-4-(3-nitrophenyl)-3-phenylthieno[2,3-b]pyridine-5-carboxylate 
• 120004-35-5 2-[(5-Amino-3-phenyl-thiophen-2-yl)-(3-nitro-phenyl)-methyl]-3-oxo-butyric acid methyl ester 
• 120004-38-8 2-[(3-Nitro-phenyl)-(5-{[1-(3-nitro-phenyl)-meth-(E)-ylidene]-amino}-3-phenyl-thiophen-2-yl)-methyl]-3-oxo-butyric acid methyl ester 
• 120004-49-1 [1-(3-Nitro-phenyl)-meth-(E)-ylidene]-(4,5,6,7-tetrahydro-benzo[b]thiophen-2-yl)-amine 
• 106970-93-8 2-Methyl-4-(3-nitro-phenyl)-1,4,5,6,7,8-hexahydro-benzo[4,5]thieno[2,3-b]pyridine-3-carboxylic acid methyl ester 
• 133147-06-5 5-Methoxycarbamoyl-2,6-dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3-carboxylic acid methyl ester 
• 133147-07-6 5-Ethoxycarbamoyl-2,6-dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3-carboxylic acid methyl ester 
• 133147-10-1 5-(2-Ethoxy-ethoxycarbamoyl)-2,6-dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3-carboxylic acid methyl ester 
• 106521-82-8 2,5-dihydro-4-methyl-2-(3-nitrophenyl)-1,5-benzothiazepine-3-carboxylic acid methyl ester 
• 39562-20-4 MN-92019 
• 123852-99-3 (E)-3-{4-(1-imidazolylmethyl)phenyl}-2-propen-1-yl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate 

Relevant articles and documents

Pharmaceutically useful dihydropyridinyldicarboxylate amides and esters incorporating arylpiperazinylalkyl moities

A series of 1,4-dihydropyridin-3,5-yl dicarboxylic acid amides and esters incorporating an arylpiperazinylalkyl moiety have been prepared possessing the general formula STR1 wherein R4 is cycloalkyl, aryl or hetaryl, generally with electronwithdrawing substituents; R2 and R6 are lower alkyl, alkanol, alkoxyalkyl, or alkylaminoalkyl; R5 is R2 or arylpiperazinylalkyl; X is 0 or NH; Y is lower alkylene, alkoxyalkylene, alkylaminoalkylene; and Z is phenyl, substituted phenyl, pyridinyl, substituted pyridinyl, or pyrimidinyl. Compounds of this series demonstrate activity as calcium and alphaadrenergic blockers in in vitro testing and antihypertensive, antiischemic, and platelet function inhibiting actions in in vivo screens.

Sila-substituted 1,4-dihydropyridine derivatives and their medicinal use

The invention provides sila-substituted 1,4-dihydropyridine derivatives useful as medicament which influence the circulation. Also included in the invention are methods for the procurement of said derivatives, compositions containing said derivatives and